Developing a core outcome set for future infertility research: an international consensus development study by Duffy, J.M.N. et al.
Developing a core outcome set for
future infertility research: an
international consensus development
study† ‡
J.M.N. Duffy1,2,*, H. AlAhwany3, S. Bhattacharya4, B. Collura5,
C. Curtis6,7, J.L.H. Evers8, R.G. Farquharson9, S. Franik10,
L.C. Giudice11,12, Y. Khalaf13, J.M.L. Knijnenburg14, B. Leeners15,
R.S. Legro16, S. Lensen17, J.C. Vazquez-Niebla18, D. Mavrelos19,
B.W.J. Mol20, C. Niederberger21, E.H.Y. Ng22,23, A.S. Otter24,
L. Puscasiu25, S. Rautakallio-Hokkanen26, S. Repping27, I. Sarris1,
J.L. Simpson28, A. Strandell29, C. Strawbridge30, H.L. Torrance31,
A. Vail32, M. van Wely27, M.A. Vercoe33, N.L. Vuong34, A.Y. Wang35,
R. Wang20, J. Wilkinson32, M.A. Youssef36, C.M. Farquhar33, and the
Core Outcome Measure for Infertility Trials (COMMIT) initiative§
1King’s Fertility, Fetal Medicine Research Institute, London, UK 2Institute for Women’s Health, University College London, London, UK
3School of Medicine, University of Nottingham, Derby, UK 4School of Medicine, Medical Sciences and Nutrition, University of Aberdeen,
UK 5RESOLVE: The National Infertility Association, VA, USA 6Fertility New Zealand, Auckland, New Zealand 7School of Psychology,
University of Waikato, Hamilton, New Zealand 8Maastricht University Medical Centre, Maastricht, The Netherlands 9Department of
Obstetrics and Gynaecology, Liverpool Women’s NHS Foundation Trust, Liverpool, UK 10Department of Obstetrics and Gynaecology,
Münster University Hospital, Münster, Germany 11Center for Research, Innovation and Training in Reproduction and Infertility, Center for
Reproductive Sciences, University of California, San Francisco, CA, USA 12International Federation of Fertility Societies, Philadelphia, PA,
USA 13Department of Women and Children’s Health, King’s College London, Guy’s Hospital, London, UK 14Freya Dutch Infertility
Association, Gorinchem, The Netherlands 15Department of Reproductive Endocrinology, University Hospital Zurich, Zurich, Switzerland
16Department of Obstetrics and Gynaecology, Penn State College of Medicine, PA, USA 17Department of Obstetrics and Gynaecology,
University of Melbourne, VIC, Australia 18Cochrane Iberoamerica, Biomedical Research Institute Sant Pau, Barcelona, Spain
19Reproductive Medicine Unit, University College Hospital, London, UK 20Department of Obstetrics and Gynaecology, Monash
University, Melbourne, Australia 21Department of Urology, University of Illinois at Chicago College of Medicine, Chicago, IL, USA
22Department of Obstetrics and Gynaecology, The University of Hong Kong, Hong Kong 23Shenzhen Key Laboratory of Fertility
Regulation, The University of Hong Kong-Shenzhen Hospital, China 24Osakidetza OSI, Bilbao, Basurto, Spain 25University of Medicine,
Pharmacy, Sciences and Technology, Targu Mures, Romania 26Fertility Europe, Evere, Belgium 27Center for Reproductive Medicine,
Amsterdam Reproduction and Development Institute, Amsterdam University Medical Centres, Amsterdam, The Netherlands
28Department of Human and Molecular Genetics, Florida International University, FL, USA 29Department of Obstetrics and Gynecology,
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WHAT IS KNOWN ALREADY: Complex issues, including a failure to consider the perspectives of people with fertility problems when
selecting outcomes, variations in outcome definitions and the selective reporting of outcomes on the basis of statistical analysis, make the
results of infertility research difficult to interpret.
STUDY DESIGN, SIZE, DURATION: A three-round Delphi survey (372 participants from 41 countries) and consensus development
workshop (30 participants from 27 countries).
PARTICIPANTS/MATERIALS, SETTING, METHODS: Healthcare professionals, researchers and people with fertility problems
were brought together in an open and transparent process using formal consensus science methods.
MAIN RESULTS AND THE ROLE OF CHANCE: The core outcome set consists of: viable intrauterine pregnancy confirmed by ultra-
sound (accounting for singleton, twin and higher multiple pregnancy); pregnancy loss (accounting for ectopic pregnancy, miscarriage, still-
birth and termination of pregnancy); live birth; gestational age at delivery; birthweight; neonatal mortality; and major congenital anomaly.
Time to pregnancy leading to live birth should be reported when applicable.
LIMITATIONS, REASONS FOR CAUTION: We used consensus development methods which have inherent limitations, including the
representativeness of the participant sample, Delphi survey attrition and an arbitrary consensus threshold.
WIDER IMPLICATIONS OF THE FINDINGS: Embedding the core outcome set within RCTs and systematic reviews should ensure
the comprehensive selection, collection and reporting of core outcomes. Research funding bodies, the Standard Protocol Items:
Recommendations for Interventional Trials (SPIRIT) statement, and over 80 specialty journals, including the Cochrane Gynaecology and
Fertility Group, Fertility and Sterility and Human Reproduction, have committed to implementing this core outcome set.
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Introduction
Randomized controlled trials (RCTs) evaluating potential fertility treat-
ments should select, collect and report outcomes that are relevant to
people with infertility and reflect the realities of clinical practice (Duffy
et al., 2017a). Unfortunately, many infertility trials fall short of this re-
quirement (Wilkinson et al., 2019a). Complex issues, including a failure
to take into account the perspectives of people with infertility when
designing RCT, variations in outcomes and selective reporting of out-
comes, make research evidence difficult to interpret, undermining the
translation of research into clinical practice (Duffy et al., 2019a).
Historically, there has been a limited emphasis upon the engagement
of people with fertility problems in the design of research, which may
have inadvertently led to the selection of outcomes based upon the
preferences of researchers. A systematic review has characterized out-
come reporting across infertility trials and demonstrates the wide varia-
tion in reporting, for example, the majority of infertility trials have not
reported live birth, major congenital anomalies and adverse events
(Dapuzzo et al., 2011). Even when relevant outcomes are reported, dif-
ferent definitions can limit interpretation. For example, live birth has
been inconsistently defined, using different definitions, including a viable
fetus after 24 weeks of gestation, pregnancy continuation beyond
28 weeks of gestation and delivery of a living baby (Wilkinson et al.,
2016). Such variation provides sufficient flexibility for researchers to se-
lectively report favorable results based on statistical significance. Selective
reporting of outcomes based on statistical significance, commonly re-
ferred to as result cherry picking, is thought to be widespread across in-
fertility research and can result in the overestimation of treatment
efficacy and underestimation of harm (Duffy et al., 2019a). Without con-
sistent outcome selection, collection and reporting, evidence synthesis
can be challenging and can make comparisons and combining these data
within a meta-analysis impossible (Braakhekke et al., 2014).
These problems can be addressed by the development of a core
outcome set for RCT and systematic reviews evaluating potential
treatments for infertility. A core outcome set represents a minimum
collection of particularly important outcomes and outcome measures
which have been developed using formal consensus methods engaging
health care professionals, researchers and people with fertility prob-
lems (Duffy et al., 2017a). Core outcomes should be routinely utilized
by researchers, collected in a standardized manner and reported
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consistently in the final publication (Core Outcomes in Women’s and
Newborn Health Initiative, 2014).
Motivated by the desire to increase the utility of future infertility re-
search, an international collaboration embedded within the Cochrane
Gynaecology and Fertility Group, has brought health care professio-
nals, researchers and people with fertility problems together to de-
velop a core outcome set for future infertility research.
Materials and methods
The study was prospectively registered with the Core Outcome
Measures in Effectiveness Trials (COMET) initiative, registration num-
ber 1023. An international steering group, including health care profes-
sionals, researchers and people with fertility problems, was
established. The steering group was convened during the development
of the study protocol, before the launch of the Delphi survey and be-
fore the consensus development meeting, to obtain advice regarding
the participant sample, data collection and data analysis.
The core outcome set was developed in a three-stage process using
consensus science methods advocated by the COMET initiative
(Williamson et al., 2017). A protocol describing the methods has pre-
viously been published (Duffy et al., 2018). The protocol was informed
by a systematic review of registered, progressing and completed core
outcome sets relevant to women’s and newborn health (Duffy et al.,
2017b) and the experiences of steering group members involved in
other core outcome set development studies (Duffy et al., 2016;
Hirsch et al., 2016a,b; Khalil et al., 2017, 2019; Webbe et al., 2017;
Whitehouse et al., 2017).
The important work of the Harbin Consensus Working Group
(Harbin Consensus Conference Workshop Group, 2014) and
International Committee for Monitoring Assisted Reproductive
Technologies (Zegers-Hochschild et al., 2017) is complementary to
this study.
A comprehensive inventory of outcomes was developed by extracting
outcomes from systematic reviews that had already quantified outcome
reporting across infertility trials (Dapuzzo et al., 2011; Braakhekke et al.,
2014; Wilkinson et al., 2016). Lay definitions were developed for individ-
ual outcomes. The outcome inventory and lay definitions were entered
into a modified Delphi method (Murphy et al., 1998).
The study aimed to recruit key stakeholders including health care
professionals, researchers and people with fertility problems.
Healthcare professionals and researchers were recruited through the
British Fertility Society, Core Outcomes in Women’s and Newborn
Health initiative, Cochrane Gynaecology and Fertility Group,
International Federation of Fertility Societies, the International
Federation of Gynecology and Obstetrics Committee for
Reproductive Medicine, Endocrinology and Infertility, Reproductive
Medicine Clinical Study Group and Royal College of Obstetricians and
Gynaecologists. People with fertility problems were recruited through
Fertility Europe, Fertility Network UK, Fertility New Zealand and
RESOLVE: The National Infertility Association. Recruitment was sup-
ported by an active social media campaign. The Delphi method does
not depend on statistical power. Working from its underlying princi-
ples, group error should decrease and the decision quality increase as
the number of participants increases. Between 10 and 15 participants
have been demonstrated to yield sufficient results and assure validity
(Murphy et al., 1998). Anticipating a 20% attrition rate, we aimed to
recruit 18 participants for each stakeholder group.
The modified Delphi method was delivered through sequential on-
line surveys using Delphi survey software (Delphi Manager, University
of Liverpool, Liverpool, UK). Potential participants received an explan-
atory video abstract, a plain language summary and Delphi survey
instructions. In round one, participants scored individual outcomes on
a nine-point Likert scale. Participants were able to select an ‘unable to
score’ category if they considered themselves not to have sufficient ex-
pertise or experience to score an individual outcome. Before complet-
ing the survey, participants were able to suggest additional outcomes.
After the round one survey had closed, the scores for each outcome
were aggregated across individual stakeholder groups. The percentage
of participants scoring each outcome at every possible response from
one to nine was calculated and tabulated for individual stakeholder
groups: healthcare professionals, researchers and people with fertility
problems. Additional outcomes were considered by the steering group
and novel outcomes were entered into the round two survey.
In round two, participants were asked to reflect on their own
scores and on the scores of other participants, before rescoring each
outcome. Before completing the survey, participants were able to
score additional outcomes suggested by participants in the round one
survey. After the round two surveys had closed, the percentage of
participants scoring each outcome at every possible response from
one to nine was calculated and tabulated for individual stakeholder
groups. An a priori consensus definition, a median score of eight in
each stakeholder group, was applied to identify consensus outcomes.
The round two Delphi survey results were reviewed by the steering
group to consider whether a further Delphi survey round was re-
quired. The steering group members concluded it was unlikely a fur-
ther Delphi survey round would identify additional consensus
outcomes. However, as there is uncertainty regarding the use of the
modified Delphi method in core outcome set development, the steer-
ing group recommended proceeding with a third Delphi survey round,
to ensure that no further consensus outcomes would have been iden-
tified (Williamson et al., 2017).
Following the round two survey, a face-to-face consensus develop-
ment meeting was arranged. A modified Nominal Group Technique
was used to further prioritize consensus outcomes. Healthcare profes-
sionals, researchers and people with fertility problems who had com-
pleted all three rounds of the Delphi survey were invited to
participate. The modified Nominal Group Technique does not depend
on statistical power. In consultation with the steering group, we aimed
to recruit between 10 and 15 participants, as this number has yielded
sufficient results and assured validity in other settings (Murphy et al.,
1998).
The modified Nominal Group Technique provides an opportunity
to generate ideas, which are discussed, and ranked by a group of
experts (Murphy et al., 1998). At the start of the meeting, the results
of the Delphi survey were reviewed. All potential core outcomes
reaching the standardized consensus definition were entered into the
process. Participants were able to enter other potential core out-
comes which had not reached the standardized consensus definition,
upon request. Each participant was asked to contribute their opinions.
Following the initial discussion, outcomes were divided into three initial
categories: outcomes to be considered for inclusion in the final core
outcome set; outcomes where no consensus existed; and outcomes
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..which should not be considered for inclusion in the final core outcome
set. Participants were invited to discuss the ordering of the outcomes
within each category. The discussion focused upon ranking the out-
comes being considered for inclusion in the final core outcome set
and the outcomes where no consensus existed. During the discussion,
the outcomes could be moved between the categories. Finally, the
core outcome set was agreed.
Results
An outcome inventory, which included 101 outcomes, was developed
(Supplementary Table SI). These outcomes were thematically ordered
into 23 thematic domains, including early pregnancy outcomes,
patient-reported outcomes and adverse events immediately following
treatment. Outcome domains, outcomes and lay definitions were en-
tered into the modified Delphi method.
When considering the Delphi survey, round one was completed by
261 healthcare professionals, 57 researchers and 54 people with fertil-
ity problems, from 41 countries (Table I). Round two was completed
by 275 participants and round three was completed by 227 partici-
pants. One hundred and one outcomes were entered into the Delphi
survey (Fig. 1). In response to the outcomes suggested by participants,
the steering group added 32 additional outcomes to round two, in-
cluding cumulative live birth, experimental intervention feasibility and
cost effectiveness. Therefore, 133 outcomes were scored during
round two. Following round two, 28 outcomes reached the consensus
threshold. No additional consensus outcomes were identified following
the completion of the round three survey.
Fifteen healthcare professionals, six researchers and nine people
with fertility problems, including four men with fertility problems, from
27 countries, participated in the consensus development meeting.
Twenty-eight consensus outcomes were entered into the modified
Nominal Group Technique. Participants entered an additional eight no
consensus outcomes into the process. These outcomes had been
highly scored by people with infertility (median score nine), however,
had not met the consensus threshold because of lower scores in other
stakeholder groups. Participants prioritized outcomes for inclusion in
the core outcome set for infertility (Fig. 2).
Discussion
Using formal consensus science methods, health care professionals,
researchers and people with fertility problems have developed a core
outcome set which should be used to standardize outcome selection,
............................................................................................................................................................................................................................
Table I Participant characteristics.
Modified Delphi method Modified nominal
group technique
Round 1 n 5 372 Round 2 n 5 275 Round 3 n 5 227 Withdrawals n 5 145 n 5 30
Stakeholder group, n
Health professionals 261 203 176 85 15
Researchers 57 44 38 19 6
People with infertility 54 28 13 41 9
Gender, n
Male 124 94 76 48 15
Female 244 178 148 96 13
Not stated 4 3 3 1 2
Age (years), n
Under 29 75 64 62 13 3
30 to 39 116 81 66 50 6
40 to 49 76 54 39 37 5
50 to 59 7 54 44 34 8
Over 60 22 18 12 10 6
Prefer not to say 5 4 4 1 0
Geographical location, n
Africa 13 5 5 8 1
Asia 118 99 94 24 2
Australia and New Zealand 42 34 29 13 3
Europe 134 92 70 64 17
North America 37 26 18 19 4
South America 15 9 5 10 2
Prefer not to say 13 10 6 7 1
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..collection and reporting across RCT and systematic reviews evaluating
potential treatments for infertility.
The COMET initiative has recently published methodological stand-
ards for core outcome set development (Kirkham et al., 2017). This
study has met these standards. With 372 participants, from 41 coun-
tries, participating in the Delphi survey and 30 participants, from 27
countries, participating in the consensus development meeting, the
global participation achieved in this study should secure the
101 potential core outcomes















Core outcome set for future infertility research
28 consensus outcomes entered
Final consensus
8 outcomes entered by participants
Systematic review
133 potential core outcomes scored
Figure 1. Flow of participants and outcomes.
Viable intrauterine pregnancy confirmed by ultrasound. Accounting for singleton 
pregnancy, twin pregnancy, and higher multiple pregnancy.
Pregnancy loss. Accounting for ectopic pregnancy, miscarriage, stillbirth, and termination 
of pregnancy. 
Live birth.




* When applicable → time to pregnancy leading to live birth.
Figure 2. A core outcome set for future infertility research.
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generalizability of the results across diverse research settings. The
study included people with fertility problems as steering group mem-
bers and participants. As participants, they shared their views regarding
the importance of potential core outcomes during the Delphi survey
and participated fully in the consensus development meeting, which
prioritized the final core outcome set. This contribution should ensure
the final core outcome set holds the necessary reach and relevance to
people with fertility problems.
This consensus study is not without limitations. Consideration
should be given to the representativeness of the study’s participants.
When considering the Delphi survey, there was a higher response
from participants who lived in Europe (134 participants; 36%). To par-
ticipate in the Delphi survey, English proficiency, a computer and inter-
net access were required. We appreciate limitations in the
representativeness of the sample could have impacted upon the out-
comes prioritized.
There is considerable uncertainty regarding core outcome set devel-
opment methods (Duffy and McManus, 2016; Williamson et al., 2017;
Duffy et al., 2019b). The optimal approaches to selecting participants,
structuring interactions, and methods of synthesizing individual judg-
ments are unclear (Murphy et al., 1998). Further methodological re-
search is required to inform future core outcome set development
(Williamson et al., 2017).
The Delphi survey’s overall attrition rate was 38%, which is compa-
rable to other core outcome development studies (Duffy et al.,
2017b). Participants who identified as people with fertility problems
were more likely to withdraw. It may have been possible to reduce at-
trition by reducing the length of the survey; for example, limiting the
outcomes entered into the Delphi survey, removing outcomes which
reached consensus in subsequent survey rounds, or reducing the num-
ber of survey rounds. However, attrition needed to be balanced with
the requirement to enter a comprehensive long list of potential core
outcomes into the Delphi survey and for participants to be able to re-
flect on and rescore individual outcomes in relation to each other.
Further methodological research is required to understand the impact
of attrition on the development of consensus within core outcome set
development studies.
Many international initiatives, professional societies and colleagues
have strongly advocated for the collection and reporting of many of
the core outcomes, including live birth, pregnancy loss and adverse
events (Barnhart, 2014; Harbin Consensus Conference Workshop
Group, 2014). Despite the clear articulation of the importance of
these outcomes, poor reporting persists with only one-third of infertil-
ity trials reporting live birth (Wilkinson et al., 2016). Why will this time
be different? The Core Outcome Measure for Infertility Trials
(COMMIT) initiative has developed a strategic plan in consultation
with a broad range of stakeholders across the research pipeline to uti-
lize available enablers to secure the routine selection, collection and
reporting of core outcomes across future fertility research (Devall
et al., 2020).
Research funding bodies are increasingly advocating for the use of
core outcome sets within the research they fund. It is considered
good practice for researchers planning RCT to follow the SPIRIT state-
ment, which outlines the scientific, ethical and administrative elements
that should be incorporated in a clinical trial protocol (Chan et al.,
2013). This statement specifically recommends the collection of core
outcomes.
This study has established a core outcome set for infertility, how-
ever different definitions exist for individual core outcomes. The study
has recently developed standardized definitions, using formal consen-
sus development methods, for individual core outcomes. This addi-
tional harmony across future infertility trials should ensure secondary
research can be undertaken prospectively, efficiently and harmoniously
(Duffy et al., 2020b). This standardization will be supported by the de-
velopment of a freely available electronic case report form and data
repository, which future researchers will be encouraged to use for
data collection (COMMIT-Collection). Several core outcomes, includ-
ing live birth, birthweight and neonatal mortality, are common to other
core outcome sets developed for hyperemesis gravidarum, multiple
pregnancy research and neonatal care (Perry et al., 2019; Webbe
et al., 2020a; Jansen et al., 2020; Townsend et al., 2020a). Additional
consistency could be achieved across our specialty if the consensus
definitions developed within this initiative were embedded within these
core outcome sets.
The CROWN initiative, supported by over 80 specialty journals, in-
cluding the Cochrane Gynaecology and Fertility Group, Fertility and
Sterility and Human Reproduction, has resolved to implement this core
outcome set (Core Outcomes in Women’s and Newborn Health
Initiative, 2014). CROWN initiative journals will advise researchers to
report the core outcome set for infertility within trial reports and offer
conclusions based on these outcomes. Where core outcome sets
have not been collected, the researchers will be asked to report this
deficiency and its implications for their findings. The COMMIT initiative
is currently developing reporting tools and templates to assist
researchers to clearly report core outcomes within their manuscripts
(COMMIT-Reporting).
Analyses of data arising from infertility trials, particularly for studies
related to ART, are frequently undermined by the use of an inappro-
priate denominator (Wilkinson, et al., 2016). Two main issues exist.
The first is the use of a post-randomization denominator, for example,
when live birth rates are calculated per embryo transferred, rather
than per woman randomized. Analyses conducted on this basis do not
reflect the randomized comparisons as the groups being compared
may differ with respect to their characteristics, and therefore, also
with respect to their outcomes (Hirji and Fagerland, 2009). The sec-
ond issue relates to analyses which commit a unit of analysis error
(Vail and Gardener, 2003). This error occurs when proportions are
calculated using an inappropriate denominator, for example, the num-
ber of oocytes or number of embryos. Unit of analysis errors com-
monly occur when researchers calculate the pregnancy rate by dividing
the number of gestational sacs on ultrasound by the number of em-
bryos transferred. As the outcomes of a couple’s embryos are corre-
lated, this approach is incorrect as standard statistical tests assume
that the tested observations are independent. To address these im-
portant issues the COMMIT initiative has resolved to reach clear rec-
ommendations regarding the selection of the most appropriate
denominator (Duffy et al., 2020b).
The Cochrane Gynaecology and Fertility Group have published over
100 systematic reviews evaluating potential treatments for infertility
and has committed to implementing the core outcome set for infertil-
ity when new and updated reviews are being prepared. Secondary re-
search, including pairwise meta-analyses, individual participant data
meta-analyses and network meta-analyses, will be more influential
when infertility trials routinely collect and report core outcomes.
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The COMMIT initiative has committed to undertaking further re-
search to assess the uptake and implementation of the core outcome
set for infertility (COMMIT-Implementation). Objectively demonstrat-
ing the uptake of the core outcome set for infertility is important to
quantify its contribution to improve the value of future research.
Assessing the uptake of the core outcome set will be undertaken by
examining registry records, published protocols, RCT and systematic
reviews, and undertaking a citation analysis. Further research is
planned to examine and understand the reasons why researchers do,
and do not, implement the core outcome set for infertility. By identify-
ing perceived barriers to implementation, strategies informed by imple-
mentation science will be developed to limit, and hopefully overcome,
any perceived barriers.
The core outcome set reported in this study is intended to be used
across trials evaluating a broad range of potential fertility treatments,
for example, male endocrine stimulation protocols, lifestyle interven-
tions for people with fertility problems, and methods for embryo se-
lection during IVF cycles. Extensions to the current core outcome set
are planned or currently in development for different patient popula-
tions, including men with fertility problems (COMMIT-Male Infertility),
women with endometriosis (Duffy et al., 2020c) and interventions in-
cluding IVF (COMMIT-IVF). Other extensions are planned to ensure
future infertility trials and systematic reviews routinely collect and re-
port harms (COMMIT-Harms). Although quality of life was not se-
lected as a core outcome, the COMMIT initiative has committed to
undertaking a systematic review and methodological assessment of
measurement instruments capable of measuring quality of life and will
make recommendations to inform the design of future infertility trials
(COMMIT-QoL).
This comprehensive strategy could make a significant contribution in
reducing research waste across future fertility research. This approach
has acted as a template for other areas of women’s health seeking to
tackle research waste, including twin and multiple pregnancy research
(Townsend et al., 2020b). The variation in outcome reporting and sus-
pected outcome reporting bias has been characterized across wom-
en’s and newborn health, including endometriosis, twin-twin
transfusion syndrome and neonatal care. This study should inform the
development of other core outcome sets seeking to tackle poorly se-
lected, collected and reported outcomes (Hirsch et al., 2016a,b; Perry
et al., 2018; Webbe et al., 2020a,b).
Research priority setting presents an opportunity to develop a prior-
itized research agenda (Graham et al., 2020). A research priority set-
ting study has recently been completed for infertility and identified
research priorities related to the prevention, diagnosis and treatment
of male, female and unexplained infertility (Duffy et al., 2020a).
Undertaking an RCT is the only appropriate method to answer many
of these research priorities (Wilkinson et al., 2019b). Therefore, it is
important for our specialty to work together to improve the design,
delivery and reporting of future trials.
In summary, this study used formal consensus methods to develop
a core outcome set for future RCT and systematic reviews evaluating
potential treatments for infertility. Embedding the core outcome set
within future infertility research could make a profound contribution to
advancing the usefulness of research to inform clinical practice and en-
hance the care people with infertility problems receive.
Supplementary data
Supplementary data are available at Human Reproduction online.
Acknowledgements
We would like to thank the Delphi survey and consensus development
meeting participants and colleagues at the Cochrane Gynaecology and
Fertility Group, University of Auckland, New Zealand.
Authors’ roles
Study concept and design: J.M.N.D., H.A., S.B., B.C., C.C., J.L.H.E.,
L.C.G., R.G.F., S.F., Y.K., R.S.L., J.M.L.K., D.M., B.W.J.M., B.L., S.L.,
C.N., E.H.Y.N., A.S.O., L.P., S.R.H., S.R., I.S., J.L.S., A.S., C.S., H.L.T.,
A.V., M.v.W., M.A.V., N.L.V., A.Y.W., R.W., J.W., M.A.Y. and C.M.F.
Acquisition of data: J.M.N.D., H.A., S.B., B.C., C.C., J.L.H.E., L.C.G.,
R.G.F., S.F., Y.K., R.S.L., J.M.L.K., D.M., B.W.J.M., B.L., S.L., C.N.,
E.H.Y.N., A.S.O., L.P., S.R.H., S.R., I.S., J.L.S., A.S., C.S., H.L.T., A.V.,
M.v.W., M.A.V., N.L.V., A.Y.W., R.W., J.W., M.A.Y. and C.M.F.
Analysis and interpretation of data: J.M.N.D., H.A., S.B., B.C., C.C.,
J.L.H.E., L.C.G., R.G.F., S.F., Y.K., R.S.L., J.M.L.K., D.M., B.W.J.M., B.L.,
S.L., C.N., E.H.Y.N., A.S.O., L.P., S.R.H., S.R., I.S., J.L.S., A.S., C.S.,
H.L.T., A.V., M.v.W., M.A.V., N.L.V., A.Y.W., R.W., J.W., M.A.Y. and
C.M.F. Drafting of the manuscript: J.M.N.D. and C.M.F. Critical revision
of the manuscript for important intellectual content: H.A., S.B., B.C.,
C.C., J.L.H.E., L.C.G., R.G.F., S.F., Y.K., R.S.L., J.M.L.K., D.M.,
B.W.J.M., B.L., S.L., C.N., E.H.Y.N., A.S.O., L.P., S.R.H., S.R., I.S.,
J.L.S., A.S., C.S., H.L.T., A.V., M.v.W., M.A.V., N.L.V., A.Y.W., R.W.,
J.W. and M.A.Y. Statistical analysis: J.M.N.D. and J.W. Study supervi-
sion: C.M.F.
Funding
This research was funded by the Catalyst Fund, Royal Society of New
Zealand, Auckland Medical Research Fund and Maurice and Phyllis
Paykel Trust. The funder had no role in the design and conduct of the
study, the collection, management, analysis or interpretation of data,
or manuscript preparation. B.W.J.M. is supported by a National Health
and Medical Research Council Practitioner Fellowship (GNT1082548).
S.B. was supported by University of Auckland Foundation Seelye
Travelling Fellowship.
Conflict of interest
S.B. reports being the Editor-in-Chief of Human Reproduction Open and
an editor of the Cochrane Gynaecology and Fertility group. J.L.H.E.
reports being the Editor Emeritus of Human Reproduction. J.M.L.K.
reports research sponsorship from Ferring and Theramex. R.S.L.
reports consultancy fees from Abbvie, Bayer, Ferring, Fractyl, Insud
Pharma and Kindex and research sponsorship from Guerbet and Hass
Avocado Board. B.W.J.M. reports consultancy fees from Guerbet,
iGenomix, Merck, Merck KGaA and ObsEva. C.N. reports being the
Co Editor-in-Chief of Fertility and Sterility and Section Editor of the
Journal of Urology, research sponsorship from Ferring, and retains a fi-
nancial interest in NexHand. A.S. reports consultancy fees from
Guerbet. E.H.Y.N. reports research sponsorship from Merck. N.L.V.







rep/article/35/12/2725/6010638 by Acquisition (Journals) Barr Sm
























































































reports consultancy and conference fees from Ferring, Merck and
Merck Sharp and Dohme. The remaining authors declare no competing
interests in relation to the work presented. All authors have completed
the disclosure form.
Appendix. Core Outcome
Measure for Infertility Trials
(COMMIT) initiative
Professor Ahmed M. Abou-Setta, University of Manitoba, Canada; Dr
Juan J. Aguilera, Argentina; Dr Oluseyi O.A. Atanda, Ladoke Akintola
University of Technology Teaching Hospital, Nigeria; Eva M.E.
Balkenende, University of Amsterdam, The Netherlands; Dr Kurt T.
Barnhart, Universtity of Pennsylvania, USA; Dr Yusuf Beebeejaun,
King’s Fertility, Fetal Medicine Research Institute, UK; Dr Sohinee
Bhattacharya, University of Aberdeen, UK; Megan Black, New
Zealand; Magdalena Bofill, University of Auckland, New Zealand;
Associate Professor Georgina M. Chambers, University of New South
Wales, Australia; Dr Abrar A. Chughtai, University of New South
Wales, Australia; Dr Javier A. Crosby, Clinica Las Condes, Chile; Dr
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